Specificity of a Pancreatic Lipase Point-of-care Test and Agreement with Pancreatic Lipase Immunoreactivity in Cats Without Clinical Evidence of Pancreatitis

Overview

Journal J Feline Med Surg

Specialty Veterinary Medicine

Date 2023 Jul 27

PMID 37498286

Authors

Panagiotis G Xenoulis

Katerina T Moraiti

Victoria M Spanou

Manolis K Chatzis

Kassiopi Cg Kokkinaki

Manolis N Saridomichelakis

Jorg M Steiner

Affiliations

Soon will be listed here.

Abstract

Objectives: The aim of this study was to determine the specificity of a rapid point-of-care test for the estimation of feline pancreatic lipase (SNAP fPL) in healthy and sick cats without clinical evidence of pancreatitis. A second objective was to evaluate the agreement between SNAP fPL and serum pancreatic lipase immunoreactivity (fPLI), as measured by Spec fPL.

Methods: A total of 150 cats were prospectively enrolled into this study. Of them, 82 cats were healthy while 68 cats had various diseases but no clinical signs (eg, anorexia, depression, vomiting) raising a suspicion of pancreatitis.

Results: SNAP fPL was normal in 133/150 cats (specificity 89%) without obvious clinical pancreatitis. SNAP fPL was normal in 74/82 healthy cats (specificity 90%) and in 59/68 cats that were sick but without typical signs of pancreatitis (specificity 87%). The agreement between SNAP fPL and Spec fPL was substantial (k = 0.64) in healthy cats and almost perfect (k = 0.93) in sick cats. The overall agreement between SNAP fPL and Spec fPL was almost perfect (k = 0.81).

Conclusions And Relevance: The specificity of SNAP fPL in this group of cats was high. There was a substantial and almost perfect agreement between the SNAP fPL and Spec fPL in healthy cats and sick cats without suspected pancreatitis, respectively. In the small percentage of cats with abnormal SNAP fPL and/or Spec fPL results, the possibility of subclinical pancreatitis cannot be excluded.

Citing Articles

Evaluation of laboratory findings indicating pancreatitis in healthy lean, obese, and diabetic cats.

Jorgensen F, Bjornvad C, Krabbe B, Nybroe S, Kieler I J Vet Intern Med. 2024; 39(1):e17236.

PMID: 39545314 PMC: 11627516. DOI: 10.1111/jvim.17236.

Cardiac biomarker concentrations in cats with elevated pancreatic lipase concentrations.

Cridge H, DeCicco B, Monterroso S, Steiner J Vet Rec. 2024; 196(3):e4599.

PMID: 39285679 PMC: 11784000. DOI: 10.1002/vetr.4599.

Evaluation of Disease Spectrum in Hospitalized Cats with Hyperlipasemia: Pancreatitis Alone Is Rare, Hyperlipasemia without Suspected Pancreatitis Is Common.

Hotz V, Brugger D, Kook P Animals (Basel). 2024; 14(10).

PMID: 38791696 PMC: 11117254. DOI: 10.3390/ani14101479.

References

Neilson-Carley S, Robertson J, Newman S, Kutchmarick D, Relford R, Woosley K . Specificity of a canine pancreas-specific lipase assay for diagnosing pancreatitis in dogs without clinical or histologic evidence of the disease. Am J Vet Res. 2011; 72(3):302-7. DOI: 10.2460/ajvr.72.3.302. View

Gerhardt A, Steiner J, Williams D, Kramer S, Fuchs C, Janthur M . Comparison of the sensitivity of different diagnostic tests for pancreatitis in cats. J Vet Intern Med. 2001; 15(4):329-33. View

Xenoulis P, Steiner J . Canine and feline pancreatic lipase immunoreactivity. Vet Clin Pathol. 2012; 41(3):312-24. DOI: 10.1111/j.1939-165X.2012.00458.x. View

De Cock H, Forman M, Farver T, Marks S . Prevalence and histopathologic characteristics of pancreatitis in cats. Vet Pathol. 2007; 44(1):39-49. DOI: 10.1354/vp.44-1-39. View

Schnauss F, Hanisch F, Burgener I . Diagnosis of feline pancreatitis with SNAP fPL and Spec fPL. J Feline Med Surg. 2018; 21(8):700-707. PMC: 6661714. DOI: 10.1177/1098612X18796624. View

Beall M, Cahill R, Pigeon K, Hanscom J, Huth S . Performance validation and method comparison of an in-clinic enzyme-linked immunosorbent assay for the detection of canine pancreatic lipase. J Vet Diagn Invest. 2011; 23(1):115-9. DOI: 10.1177/104063871102300120. View

Xenoulis P, Moraiti K, R Finco D, Suchodolski J, Steiner J . Serum feline pancreatic lipase immunoreactivity and trypsin-like immunoreactivity concentrations in cats with experimentally induced chronic kidney disease. J Vet Intern Med. 2021; 35(6):2821-2827. PMC: 8692220. DOI: 10.1111/jvim.16296. View

McCord K, Morley P, Armstrong J, Simpson K, Rishniw M, Forman M . A multi-institutional study evaluating the diagnostic utility of the spec cPL™ and SNAP® cPL™ in clinical acute pancreatitis in 84 dogs. J Vet Intern Med. 2012; 26(4):888-96. DOI: 10.1111/j.1939-1676.2012.00951.x. View

Xenoulis P, Steiner J . SNAP Tests for Pancreatitis in Dogs and Cats: SNAP Canine Pancreatic Lipase and SNAP Feline Pancreatic Lipase. Top Companion Anim Med. 2017; 31(4):134-139. DOI: 10.1053/j.tcam.2016.10.005. View

10.

Oppliger S, Hartnack S, Riond B, Reusch C, Kook P . Agreement of the serum Spec fPL™ and 1,2-o-dilauryl-rac-glycero-3-glutaric acid-(6'-methylresorufin) ester lipase assay for the determination of serum lipase in cats with suspicion of pancreatitis. J Vet Intern Med. 2013; 27(5):1077-82. DOI: 10.1111/jvim.12150. View

11.

Kook P, Kohler N, Hartnack S, Riond B, Reusch C . Agreement of serum Spec cPL with the 1,2-o-dilauryl-rac-glycero glutaric acid-(6'-methylresorufin) ester (DGGR) lipase assay and with pancreatic ultrasonography in dogs with suspected pancreatitis. J Vet Intern Med. 2014; 28(3):863-70. PMC: 4895468. DOI: 10.1111/jvim.12334. View

12.

Steiner J, Wilson B, Williams D . Development and analytical validation of a radioimmunoassay for the measurement of feline pancreatic lipase immunoreactivity in serum. Can J Vet Res. 2004; 68(4):309-14. PMC: 1111363. View

13.

Lee C, Kathrani A, Maddison J . Retrospective study of the diagnostic utility of Spec fPLin the assessment of 274 sick cats. J Vet Intern Med. 2020; 34(4):1406-1412. PMC: 7379029. DOI: 10.1111/jvim.15797. View

14.

Forman M, Marks S, De Cock H, Hergesell E, Wisner E, Baker T . Evaluation of serum feline pancreatic lipase immunoreactivity and helical computed tomography versus conventional testing for the diagnosis of feline pancreatitis. J Vet Intern Med. 2005; 18(6):807-15. DOI: 10.1892/0891-6640(2004)18<807:eosfpl>2.0.co;2. View

15.

Haworth M, Hosgood G, Swindells K, Mansfield C . Diagnostic accuracy of the SNAP and Spec canine pancreatic lipase tests for pancreatitis in dogs presenting with clinical signs of acute abdominal disease. J Vet Emerg Crit Care (San Antonio). 2014; 24(2):135-43. DOI: 10.1111/vec.12158. View

16.

Xenoulis P, Steiner J . Current concepts in feline pancreatitis. Top Companion Anim Med. 2008; 23(4):185-92. DOI: 10.1053/j.tcam.2008.08.005. View

17.

Cridge H, MacLeod A, Pachtinger G, Mackin A, Sullivant A, Thomason J . Evaluation of SNAP cPL, Spec cPL, VetScan cPL Rapid Test, and Precision PSL Assays for the Diagnosis of Clinical Pancreatitis in Dogs. J Vet Intern Med. 2018; 32(2):658-664. PMC: 5866996. DOI: 10.1111/jvim.15039. View

18.

Trivedi S, Marks S, Kass P, Luff J, Keller S, Johnson E . Sensitivity and specificity of canine pancreas-specific lipase (cPL) and other markers for pancreatitis in 70 dogs with and without histopathologic evidence of pancreatitis. J Vet Intern Med. 2011; 25(6):1241-7. DOI: 10.1111/j.1939-1676.2011.00793.x. View

19.

Oppliger S, Hilbe M, Hartnack S, Zini E, Reusch C, Kook P . Comparison of Serum Spec fPL(™) and 1,2-o-Dilauryl-Rac-Glycero-3-Glutaric Acid-(6'-Methylresorufin) Ester Assay in 60 Cats Using Standardized Assessment of Pancreatic Histology. J Vet Intern Med. 2016; 30(3):764-70. PMC: 4913568. DOI: 10.1111/jvim.13924. View

20.

Watson P, Archer J, Roulois A, Scase T, Herrtage M . Observational study of 14 cases of chronic pancreatitis in dogs. Vet Rec. 2011; 167(25):968-76. DOI: 10.1136/vr.c4912. View